LPS-Enhanced Glucose-Stimulated Insulin Secretion Is Normalized by Resveratrol

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

LPS-Enhanced Glucose-Stimulated Insulin Secretion Is Normalized by Resveratrol. / Nøhr, Mark Klitgaard; Dudele, Anete; Poulsen, Morten Møller; Ebbesen, Lene Hyldahl; Radko, Yulia; Christensen, Lars P.; Jessen, Niels; Richelsen, Bjørn; Lund, Sten; Pedersen, Steen Bønløkke.

I: PloS one, Bind 11, Nr. 1, e0146840, 2016.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Nøhr, MK, Dudele, A, Poulsen, MM, Ebbesen, LH, Radko, Y, Christensen, LP, Jessen, N, Richelsen, B, Lund, S & Pedersen, SB 2016, 'LPS-Enhanced Glucose-Stimulated Insulin Secretion Is Normalized by Resveratrol', PloS one, bind 11, nr. 1, e0146840. https://doi.org/10.1371/journal.pone.0146840

APA

Nøhr, M. K., Dudele, A., Poulsen, M. M., Ebbesen, L. H., Radko, Y., Christensen, L. P., ... Pedersen, S. B. (2016). LPS-Enhanced Glucose-Stimulated Insulin Secretion Is Normalized by Resveratrol. PloS one, 11(1), [e0146840]. https://doi.org/10.1371/journal.pone.0146840

Vancouver

Nøhr MK, Dudele A, Poulsen MM, Ebbesen LH, Radko Y, Christensen LP o.a. LPS-Enhanced Glucose-Stimulated Insulin Secretion Is Normalized by Resveratrol. PloS one. 2016;11(1). e0146840. https://doi.org/10.1371/journal.pone.0146840

Author

Nøhr, Mark Klitgaard ; Dudele, Anete ; Poulsen, Morten Møller ; Ebbesen, Lene Hyldahl ; Radko, Yulia ; Christensen, Lars P. ; Jessen, Niels ; Richelsen, Bjørn ; Lund, Sten ; Pedersen, Steen Bønløkke. / LPS-Enhanced Glucose-Stimulated Insulin Secretion Is Normalized by Resveratrol. I: PloS one. 2016 ; Bind 11, Nr. 1.

Bibtex

@article{0be91f0c0eb841058ea88a0680e12750,
title = "LPS-Enhanced Glucose-Stimulated Insulin Secretion Is Normalized by Resveratrol",
abstract = "UNLABELLED: Low-grade inflammation is seen with obesity and is suggested to be a mediator of insulin resistance. The eliciting factor of low-grade inflammation is unknown but increased permeability of gut bacteria-derived lipopolysaccharides (LPS) resulting in endotoxemia could be a candidate. Here we test the effect of LPS and the anti-inflammatory compound resveratrol on glucose homeostasis, insulin levels and inflammation. Mice were subcutaneously implanted with osmotic mini pumps infusing either low-dose LPS or saline for 28 days. Half of the mice were treated with resveratrol delivered through the diet. LPS caused increased inflammation of the liver and adipose tissue (epididymal and subcutaneous) together with enlarged spleens and increased number of leukocytes in the blood. Resveratrol specifically reduced the inflammatory status in epididymal fat (reduced expression of TNFa and Il1b, whereas the increased macrophage infiltration was unaltered) without affecting the other tissues investigated. By LC-MS, we were able to quantitate resveratrol metabolites in epididymal but not subcutaneous adipose tissue. LPS induced insulin resistance as the glucose-stimulated insulin secretion during an oral glucose tolerance test was increased despite similar plasma glucose level resulting in an increase in the insulinogenic index (IGI; delta0-15insulin/delta0-15glucose) from 13.73 to 22.40 pmol/mmol (P < 0.001). This aberration in insulin and glucose homeostasis was normalized by resveratrol.IN CONCLUSION: Low-dose LPS enhanced the glucose-stimulated insulin secretion without affecting the blood glucose suggesting increased insulin resistance. Resveratrol restored LPS-induced alteration of the insulin secretion and demonstrated anti-inflammatory effects specifically in epididymal adipose tissue possibly due to preferential accumulation of resveratrol metabolites pointing towards a possible important involvement of this tissue for the effects on insulin resistance and insulin secretion.",
keywords = "Adipose Tissue/pathology, Animals, Antioxidants/chemistry, Blood Glucose/analysis, Body Weight, Epididymis, Gene Expression Profiling, Glucose/chemistry, Glucose Tolerance Test, Homeostasis, Inflammation, Insulin/secretion, Insulin Resistance, Leukocytes/cytology, Lipopolysaccharides/chemistry, Liver/pathology, Male, Mice, Mice, Inbred C57BL, Obesity/drug therapy, Osmosis, Stilbenes/chemistry",
author = "N{\o}hr, {Mark Klitgaard} and Anete Dudele and Poulsen, {Morten M{\o}ller} and Ebbesen, {Lene Hyldahl} and Yulia Radko and Christensen, {Lars P.} and Niels Jessen and Bj{\o}rn Richelsen and Sten Lund and Pedersen, {Steen B{\o}nl{\o}kke}",
year = "2016",
doi = "10.1371/journal.pone.0146840",
language = "English",
volume = "11",
journal = "P L o S One",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "1",

}

RIS

TY - JOUR

T1 - LPS-Enhanced Glucose-Stimulated Insulin Secretion Is Normalized by Resveratrol

AU - Nøhr, Mark Klitgaard

AU - Dudele, Anete

AU - Poulsen, Morten Møller

AU - Ebbesen, Lene Hyldahl

AU - Radko, Yulia

AU - Christensen, Lars P.

AU - Jessen, Niels

AU - Richelsen, Bjørn

AU - Lund, Sten

AU - Pedersen, Steen Bønløkke

PY - 2016

Y1 - 2016

N2 - UNLABELLED: Low-grade inflammation is seen with obesity and is suggested to be a mediator of insulin resistance. The eliciting factor of low-grade inflammation is unknown but increased permeability of gut bacteria-derived lipopolysaccharides (LPS) resulting in endotoxemia could be a candidate. Here we test the effect of LPS and the anti-inflammatory compound resveratrol on glucose homeostasis, insulin levels and inflammation. Mice were subcutaneously implanted with osmotic mini pumps infusing either low-dose LPS or saline for 28 days. Half of the mice were treated with resveratrol delivered through the diet. LPS caused increased inflammation of the liver and adipose tissue (epididymal and subcutaneous) together with enlarged spleens and increased number of leukocytes in the blood. Resveratrol specifically reduced the inflammatory status in epididymal fat (reduced expression of TNFa and Il1b, whereas the increased macrophage infiltration was unaltered) without affecting the other tissues investigated. By LC-MS, we were able to quantitate resveratrol metabolites in epididymal but not subcutaneous adipose tissue. LPS induced insulin resistance as the glucose-stimulated insulin secretion during an oral glucose tolerance test was increased despite similar plasma glucose level resulting in an increase in the insulinogenic index (IGI; delta0-15insulin/delta0-15glucose) from 13.73 to 22.40 pmol/mmol (P < 0.001). This aberration in insulin and glucose homeostasis was normalized by resveratrol.IN CONCLUSION: Low-dose LPS enhanced the glucose-stimulated insulin secretion without affecting the blood glucose suggesting increased insulin resistance. Resveratrol restored LPS-induced alteration of the insulin secretion and demonstrated anti-inflammatory effects specifically in epididymal adipose tissue possibly due to preferential accumulation of resveratrol metabolites pointing towards a possible important involvement of this tissue for the effects on insulin resistance and insulin secretion.

AB - UNLABELLED: Low-grade inflammation is seen with obesity and is suggested to be a mediator of insulin resistance. The eliciting factor of low-grade inflammation is unknown but increased permeability of gut bacteria-derived lipopolysaccharides (LPS) resulting in endotoxemia could be a candidate. Here we test the effect of LPS and the anti-inflammatory compound resveratrol on glucose homeostasis, insulin levels and inflammation. Mice were subcutaneously implanted with osmotic mini pumps infusing either low-dose LPS or saline for 28 days. Half of the mice were treated with resveratrol delivered through the diet. LPS caused increased inflammation of the liver and adipose tissue (epididymal and subcutaneous) together with enlarged spleens and increased number of leukocytes in the blood. Resveratrol specifically reduced the inflammatory status in epididymal fat (reduced expression of TNFa and Il1b, whereas the increased macrophage infiltration was unaltered) without affecting the other tissues investigated. By LC-MS, we were able to quantitate resveratrol metabolites in epididymal but not subcutaneous adipose tissue. LPS induced insulin resistance as the glucose-stimulated insulin secretion during an oral glucose tolerance test was increased despite similar plasma glucose level resulting in an increase in the insulinogenic index (IGI; delta0-15insulin/delta0-15glucose) from 13.73 to 22.40 pmol/mmol (P < 0.001). This aberration in insulin and glucose homeostasis was normalized by resveratrol.IN CONCLUSION: Low-dose LPS enhanced the glucose-stimulated insulin secretion without affecting the blood glucose suggesting increased insulin resistance. Resveratrol restored LPS-induced alteration of the insulin secretion and demonstrated anti-inflammatory effects specifically in epididymal adipose tissue possibly due to preferential accumulation of resveratrol metabolites pointing towards a possible important involvement of this tissue for the effects on insulin resistance and insulin secretion.

KW - Adipose Tissue/pathology

KW - Animals

KW - Antioxidants/chemistry

KW - Blood Glucose/analysis

KW - Body Weight

KW - Epididymis

KW - Gene Expression Profiling

KW - Glucose/chemistry

KW - Glucose Tolerance Test

KW - Homeostasis

KW - Inflammation

KW - Insulin/secretion

KW - Insulin Resistance

KW - Leukocytes/cytology

KW - Lipopolysaccharides/chemistry

KW - Liver/pathology

KW - Male

KW - Mice

KW - Mice, Inbred C57BL

KW - Obesity/drug therapy

KW - Osmosis

KW - Stilbenes/chemistry

U2 - 10.1371/journal.pone.0146840

DO - 10.1371/journal.pone.0146840

M3 - Journal article

C2 - 26751381

VL - 11

JO - P L o S One

JF - P L o S One

SN - 1932-6203

IS - 1

M1 - e0146840

ER -

ID: 195591582